Clinical Trial

A Study of GR1803 in Systemic Lupus Erythematosus

Name: A Study of GR1803 in Systemic Lupus Erythematosus — clinical trial record (NCT07348055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-09.

Trial Details

NCT Number	NCT07348055
Lead Sponsor	Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Conditions	Systemic Lupus Erthematosus, Auto Immune Disease
Enrollment	44 participants
Start Date	2026-02-02
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-10